↓ Skip to main content
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
30 X users
patent
1 patent
guideline
3 clinical guideline sources

Readers on

mendeley
177 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Published in
Lancet Oncology, June 2021
DOI 10.1016/s1470-2045(21)00216-3
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 177 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 17 10%
Student > Bachelor 12 7%
Other 11 6%
Student > Doctoral Student 9 5%
Student > Ph. D. Student 8 5%
Other 25 14%
Unknown 95 54%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 41 23%
Biochemistry, Genetics and Molecular Biology 9 5%
Nursing and Health Professions 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 6 3%
Immunology and Microbiology 4 2%
Other 9 5%
Unknown 101 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2026.
All research outputs
#1,164,929
of 34,652,893 outputs
Outputs from Lancet Oncology
#1,500
of 8,024 outputs
Outputs of similar age
#23,584
of 488,519 outputs
Outputs of similar age from Lancet Oncology
#39
of 122 outputs
Altmetric has tracked 34,652,893 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,024 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 488,519 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.